N/A
Manufactured by ThePharmaNetwork, LLC
17,794 FDA adverse event reports analyzed
Last updated: 2026-04-14
DRONABINOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ThePharmaNetwork, LLC. The most commonly reported adverse reactions for DRONABINOL include NAUSEA, FATIGUE, DIARRHOEA, DEATH, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DRONABINOL.
Out of 7,815 classified reports for DRONABINOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 17,794 FDA FAERS reports that mention DRONABINOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, FATIGUE, DIARRHOEA, DEATH, VOMITING, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ThePharmaNetwork, LLC in connection with DRONABINOL. Always verify the specific product and NDC with your pharmacist.